Table 2.
Patient-reported outcomes.
| Measurement | T1a, mean (SD, range) | T1, median (IQR) | T1-T2b, median (IQR) | P valuec | T1-T3d, median (IQR) | P valuee | |
| SPARCf |
|
|
|
|
|
|
|
|
|
Physical | 12.88 (8.87, 2.00-31.50) | 12.53 (13.5) | 2.00 (10) | .196 | 4.50 (7.25) | .123 |
|
|
Psychological/emotional | 3.28 (2.89, 0.00-9.00) | 3.00 (5.25) | 1.00 (2.00) | .049 | 1.00 (2.5) | .572 |
|
|
Spiritual/religious | 0.67 (0.97, 0.00-3.00) | 0.00 (1.25) | 0.00 (1.00) | .161 | 0.00 (1.00) | .102 |
|
|
Independence | 1.11 (1.23, 0.00-4.00) | 1.00 (2.00) | 0.00 (0.00) | 1.00 | 0.00 (1.50) | .180 |
|
|
Family/social | 1.00 (0.89, 0.00-3.00) | 1.00 (1.50) | 0.00 (0.5) | 1.00 | 0.00 (0.75) | 1.00 |
|
|
Treatment concerns | 1.24 (1.56, 0.00-6.00) | 1.00 (2.00) | 0.00 (3.00) | .755 | 0.00 (2.5) | .683 |
| TAMg |
|
|
|
|
|
|
|
|
|
Ease of use | 4.93 (1.08, 3.33-7.00) | 5.00 (2.09) | -1.17 (1.67) | .196 | –0.50 (2.00) | .352 |
|
|
Usefulness | 5.94 (0.84, 4.00-7.00) | 6.00 (1.1) | 0.00 (3.4) | .022 | –0.30 (3.4) | .671 |
| LCSS-Mesoh | 23.40 (18.12, 2.25-63.75) | 13.69 (31.38) | –0.38 (26.88) | .859 | –0.25 (28.06) | .575 | |
aT1: baseline.
bT2: 6 weeks or 8 weeks.
cComparing the change in median values from T1 to T2.
dT3: end of the study.
eComparing the change in median values from T1 to T3.
fSPARC: Sheffield Profile for Assessment and Referral for Care.
gTAM: Technology Acceptance Model.
hLCSS-Meso: Lung Cancer Symptom Scale-Mesothelioma.